TNFSF10 and Sepsis: Consequently, the administration of soluble TRAIL or agonistic αDR5-antibodies increased neutrophil apoptosis, leading to ameliorated inflammation following Streptococcus pneumoniae infection [31] and during sepsis induced by bacteria [32,34] or TLR-ligands [39].